Reminder - Covidien (COV) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 1/24/14, Covidien plc ( COV) will trade ex-dividend, for its quarterly dividend of $0.32, payable on 2/20/14. As a percentage of COV's recent stock price of $68.41, this dividend works out to approximately 0.47%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for COV, showing historical dividends prior to the most recent $0.32 declared by Covidien plc:

COV+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from COV is likely to continue, and whether the current estimated yield of 1.87% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of COV shares, versus its 200 day moving average:

Covidien plc 200 Day Moving Average Chart

Looking at the chart above, COV's low point in its 52 week range is $54.43 per share, with $69.98 as the 52 week high point — that compares with a last trade of $68.36.

According to the ETF Finder at ETF Channel, COV makes up 6.38% of the iShares U.S. Medical Devices ETF ( IHI) which is trading lower by about 0.2% on the day Wednesday.

In Wednesday trading, Covidien plc shares are currently up about 0.3% on the day.

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback